Anzeige
Mehr »
Dienstag, 01.07.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
571 Leser
Artikel bewerten:
(2)

Medsential LLC: Medsential Now Offering COVID-19 Rapid Antibody Test Kits Nationwide

SALT LAKE CITY, UT / ACCESSWIRE / April 22, 2020 / U.S.-based Medsential is now offering COVID-19 IgM/IgG rapid antibody tests beginning in April. These COVID-19 IgM/IgG testing kits will be available to laboratories and health care workers at the point-of-care under the updated guidelines issued by the FDA on March 16, 2020. Medsential is an FDA-registered medical device company and is operating in compliance with the FDA to begin distribution.

"In March, Medsential introduced antibody testing to federal and state leaders. We had early access to antibody test samples mid-March," said Chiao-ih Hui, COO of Medsential. "We knew they would be a significant game-changer to coronavirus testing across the nation. Our COVID-19 test provides results within 15 minutes on-the-spot and are easy to use. The test device is low-cost so repeat testing is cost-effective. Our test does not require any other external reading device. It requires only a finger prick."

These particular COVID-19 tests are widely used internationally and this test has CE certification in the EU. These tests are undergoing independent validation in the U.S. and Medsential has filed an EUA with the FDA. Medsential has manufacturing and distribution operations in the U.S., China and Japan and will be able to meet high-volume demand for these antibody tests.

"Our rapid test kits show three levels of antibody build-up, unlike other antibody tests that show only one," said Hui. "This allows for more accurate identification of community spread and exposure to coronavirus. Health care providers can assess the exposure of their staff and their patients to better protect vulnerable populations, including detecting COVID-19 before symptoms occur. In addition, our test can identify immunity to the virus as our bodies build up antibodies."

U.S. Sen. Orrin Hatch said, "It's critical that countries work together to solve this pandemic. That's why we've reached out to international leaders to help U.S. manufacturers and researchers in the great work they are doing to bring tests to as many Americans as possible."

"Medsential's testing kit will help broaden testing efforts so that we can slow the spread of coronavirus, and get our economy back on track," said U.S. Rep. John Curtis.

The updated FDA guidelines specifically contemplate the use of Medsential's type of IgM/IgG testing stating that "[The FDA] does not intend to object if companies start offering "serology' tests, which can infer the presence of the new coronavirus by detecting specific blood cells produced in response to the virus."

# # #

About Medsential

Medsential LLC is a U.S. company that develops, manufactures, and distributes a broad range of medical products to customers. Established in 2005, Medsential is an ISO certified medical device company with the capabilities to develop, manufacture and assemble a broad range of products. Medsential has an extensive distribution channel, sales force, engineering platform, and production team to bring quality products to global markets. We also work with partner companies to provide clinical trial tests, distribution, manufacturing, and assembly. Medsential has manufacturing and distribution operations in the U.S., China and Japan.

Learn more: www.medsential.com

For photo click here.

For b-roll footage (25MB) click here.

Contact: Press@Medsential.com

SOURCE: Medsential LLC



View source version on accesswire.com:
https://www.accesswire.com/585217/Medsential-Now-Offering-COVID-19-Rapid-Antibody-Test-Kits-Nationwide

© 2020 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.